Treatment of retractile scar after a hypetrophic scar (HSs) in the hand with ADM (Dermacell)
1 Lefkada General Hospital, Lefkada, Greece.
2 Department of Biotechnologies, University of Padova, Italy.
3 U.O. Geriatry - Diabetology, Santa Maria del Carmine Hospital, Rovereto, Italy.
Research Article
International Journal of Frontiers in Science and Technology Research, 2022, 03(02), 001–004.
Article DOI: 10.53294/ijfstr.2022.3.2.0052
Publication history:
Received on 26 August 2022; revised on 02 October 2022; accepted on 05 October 2022
Abstract:
Hypertrophic scars can occur anywhere on skin after a skin injury or wound.
The reason is not fully understood, the result is the abnormal production of extra collagen and a decrease in elastin, which lead to these undesirable thick, raised stiff scars.
Sometimes surgery is performed to cut out the scar or redirect the lines of tension on the scar. Usually, surgery is considered when other treatment options have failed.
Dermacell is human acellular matrix (hADM) that is intended for supplemental support and covering for soft tissue repair. It acts as ECM. The expression and proliferation of extracellular matrix (ECM) molecules in the dermis, mediated by a range of growth factors and cytokines, is a fundamental element of wound repair.
Keywords:
Skin tear; Hypertrophic scar; Skin substitutes; Skin dressings; Matrices; HADM; Trauma
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0